EUVIMEDEUVIMED entdecken
Crossref

Alzheimer’s and the Gut Microbiota: Impacts on Brain Health, Memory, and Inflammation

Microbial Bioactives · 01.07.2025 · 8 (1) · 1-9

DOI: 10.25163/microbbioacts.8110303 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Bioactives, online erschienen am 01.07.2025.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder marked by cognitive decline, memory loss, and neuronal degeneration. While genetic and environmental factors are well-established contributors, growing evidence highlights the gut microbiome as a potential modifiable risk factor in AD pathogenesis. The gut-brain axis, a complex communication network between the gastrointestinal tract and the central nervous system, plays a vital role in regulating inflammation, immune responses, and neurochemical signaling. Dysbiosis—an imbalance in gut microbial composition—has been associated with neuroinflammation, amyloid-beta accumulation, blood-brain barrier disruption, and cognitive dysfunction. Recent studies suggest that pathogenic bacteria such as Escherichia coli and Bacteroides fragilis may exacerbate amyloid-beta deposition and inflammation, while beneficial microbes like Lactobacillus and Bifidobacterium offer neuroprotective effects. Microbial metabolites, particularly short-chain fatty acids (SCFAs), are critical for maintaining neuronal health; diminished SCFA production correlates with increased inflammation and AD progression. Additionally, gut-derived lipopolysaccharides (LPS) can trigger systemic immune responses and chronic neuroinflammation via increased gut permeability (“leaky gut”). Probiotic and prebiotic interventions have shown promise in restoring microbial balance and improving cognitive outcomes, though clinical validation remains limited. Understanding the gut microbiome's influence on AD not only offers novel insights into disease mechanisms but also opens avenues for early diagnosis and microbiome-based therapeutic strategies. Continued research is essential to clarify causal relationships and develop effective interventions.

Zitieren

APA

(2025). Alzheimer’s and the Gut Microbiota: Impacts on Brain Health, Memory, and Inflammation. Microbial Bioactives, 8(1), 1-9. https://doi.org/10.25163/microbbioacts.8110303

Vancouver

Alzheimer’s and the Gut Microbiota: Impacts on Brain Health, Memory, and Inflammation. Microbial Bioactives. 2025;8(1):1-9. doi:10.25163/microbbioacts.8110303

BibTeX
@article{euvimed2025,
  title = {Alzheimer’s and the Gut Microbiota: Impacts on Brain Health, Memory, and Inflammation},
  journal = {Microbial Bioactives},
  year = {2025},
  volume = {8},
  number = {1},
  pages = {1--9},
  doi = {10.25163/microbbioacts.8110303}
}
Kostenlos starten →